Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology

被引:25
作者
Woenckhaus, M
Grepmeier, U
Werner, B
Schulz, C
Rockmann, F
Wild, PJ
Röckelein, G
Blaszyk, H
Schuierer, M
Hofstaedter, F
Hartmann, A
Dietmaier, W
机构
[1] Univ Regensburg, Dept Pathol, D-93053 Regensburg, Germany
[2] Univ Regensburg, Dept Internal Med, D-93053 Regensburg, Germany
[3] Hosp Donaustauf, Dept Internal Med, Donaustauf, Germany
[4] Inst Pathol, Regensburg, Germany
[5] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA
关键词
D O I
10.1016/S1525-1578(10)60583-1
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Pleural effusions may result from various inflammatory, hemodynamic, or neoplastic conditions. A common diagnostic problem lies in distinguishing malignant from benign pleural effusions using routine cytological evaluation. We studied pleural fluid samples obtained from 14 patients with histologically confirmed malignancy and from 6 patients with benign pleural effusions using 12 microsatellite markers from 8 different chromosomal regions. Supernatants and cellular sediments of all 20 pleural fluid samples were analyzed. Routine cytological examination was 100% specific for malignancy but was only 57% sensitive. Microsatellite analyses of pleural fluid supernatants showed genetic alterations in tumor patients only. However, 50% of pleural effusions that were considered negative for malignancy by routine cytological analysis showed either loss of heterozygosity or microsatellite instability. The sensitivity of pleural fluid examination rose to 79% when routine cytological assessment was supplemented by molecular studies. Our data suggest that microsatellite analysis increases the sensitivity of cytological pleural fluid examination in assessing potential malignancy and that combining cytological and molecular methods may improve yield and certainty in diagnostically challenging cases.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 78 条
[1]
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma [J].
Ahmed, M ;
Giles, F ;
Joe, Y ;
Weber, DM ;
Jilani, I ;
Manshouri, T ;
Giralt, S ;
De Lima, M ;
Keating, M ;
Albitar, M .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (03) :174-178
[2]
Ahrendt S A, 1999, Surg Oncol Clin N Am, V8, P641
[3]
Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer [J].
Ahrendt, SA ;
Chow, JT ;
Xu, LH ;
Yang, SC ;
Eisenberger, CF ;
Esteller, M ;
Herman, JG ;
Wu, L ;
Decker, PA ;
Jen, J ;
Sidransky, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (04) :332-339
[4]
Ahrendt SA, 2000, CANCER RES, V60, P3155
[5]
Ahrendt SA, 2000, CANCER RES, V60, P2488
[6]
Primary intrathoracic malignant effusion - A descriptive study [J].
Ang, P ;
Tan, EH ;
Leong, SS ;
Koh, L ;
Eng, P ;
Agasthian, T ;
Cheah, FK .
CHEST, 2001, 120 (01) :50-54
[7]
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients [J].
Anker, P ;
Mulcahy, H ;
Chen, XQ ;
Stroun, M .
CANCER AND METASTASIS REVIEWS, 1999, 18 (01) :65-73
[8]
Belinsky SA, 2002, CANCER RES, V62, P2370
[9]
Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR [J].
Braga, E ;
Senchenko, V ;
Bazov, I ;
Loginov, W ;
Liu, J ;
Ermilova, V ;
Kazubskaya, T ;
Garkavtseva, R ;
Mazurenko, N ;
Kisseljov, F ;
Lerman, MI ;
Klein, G ;
Kisselev, L ;
Zabarovsky, ER .
INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (05) :534-541
[10]
Pitfalls in TRAP assay in routine detection of malignancy in effusions [J].
Braunschweig, R ;
Guilleret, I ;
Delacrétaz, F ;
Bosman, FT ;
Mihaescu, A ;
Benhattar, J .
DIAGNOSTIC CYTOPATHOLOGY, 2001, 25 (04) :225-230